Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bicara Therapeutics Inc. Common Stock
Market Cap
$1.14B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$1.14B
Net Profit Margin
-13.51%
TTM Avg
-5.33%
3Y Avg
-11.32%
5Y Avg
-12.84%
Market Cap
$1.12B
Net Profit Margin
-5.43%
TTM Avg
-0.76%
3Y Avg
-19.17%
5Y Avg
-21.06%
Market Cap
$1.12B
Net Profit Margin
10.76%
TTM Avg
17.71%
3Y Avg
18.77%
5Y Avg
14.94%
Market Cap
$1.16B
Net Profit Margin
2.07%
TTM Avg
2.94%
3Y Avg
0.11%
5Y Avg
-9.38%
Market Cap
$1.11B
Net Profit Margin
26.70%
TTM Avg
26.54%
3Y Avg
25.84%
5Y Avg
21.67%
Market Cap
$1.20B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.21B
Net Profit Margin
30.98%
TTM Avg
14.24%
3Y Avg
-62.70%
5Y Avg
-170.15%
Market Cap
$1.05B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. Common Stock (BCAX) | $1.14B | 0.00% | 0.00% | 0.00% | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | -13.51% | -5.33% | -11.32% | -12.84% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -5.43% | -0.76% | -19.17% | -21.06% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 10.76% | 17.71% | 18.77% | 14.94% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 2.07% | 2.94% | 0.11% | -9.38% |
| IRadimed Corporation (IRMD)vs › | $1.11B | 26.70% | 26.54% | 25.84% | 21.67% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | 0.00% | 0.00% | 0.00% | 0.00% |
| Cronos Group Inc. (CRON)vs › | $1.21B | 30.98% | 14.24% | -62.70% | -170.15% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.13% | -23.45% | -155.72% | -114.72% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.26% | -1.90% | -3.13% | -3.39% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
